Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ALM-401 by Almirall for Autoimmune Disorders: Likelihood of Approval
ALM-401 is under clinical development by Almirall and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...
ALM-412 by Almirall for Familial Adenomatous Polyposis: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis. According to GlobalData, Phase...
ALM-223 by Almirall for Systemic Lupus Erythematosus: Likelihood of Approval
ALM-223 is under clinical development by Almirall and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase...
ALM-412 by Almirall for Epidermolysis Bullosa: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Epidermolysis Bullosa. According to GlobalData, Phase I...